Skip to main content

General AI News

Generative AI is building drugs faster than systems can regulate them

Source: Devdiscourse
Generative AI is building drugs faster than systems can regulate them

Generative AI is accelerating drug discovery and development at a pace that outstrips current regulatory frameworks, creating potential safety and efficacy concerns. Researchers warn that while AI-designed drugs could reach patients faster, existing oversight systems are unprepared to evaluate and approve these novel compounds, necessitating urgent updates to regulatory processes.

Read Full Article at Devdiscourse

Related Articles